Cardlytics Inc Cash Flow-to-Debt Ratio
Cardlytics Inc cash flow-to-debt ratio. Cardlytics Inc (CDLX) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of $-5.64 Million could theoretically repay 0% of its total liabilities ($267.91 Million) in one year. Check CDLX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cardlytics Inc (2015–2025)
Cash flow-to-debt ratio of Cardlytics Inc from 2015 to 2025. Historical debt coverage capacity for Cardlytics Inc across 11 annual periods. Check Cardlytics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Cardlytics Inc Cash Flow-to-Debt Ratio by Year (2015–2025)
Cardlytics Inc cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Cardlytics Inc. For the full cash flow conversion analysis, see CDLX operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $9.29 Million | $292.15 Million | ▲ +216.3% |
| 2024 | -0.03x | $-8.82 Million | $322.72 Million | ▼ -6393.5% |
| 2023 | 0.00x | $-185.00K | $439.35 Million | ▲ +99.6% |
| 2022 | -0.11x | $-53.90 Million | $479.63 Million | ▼ -67.2% |
| 2021 | -0.07x | $-38.52 Million | $573.10 Million | ▼ -134.7% |
| 2020 | -0.03x | $-7.60 Million | $265.35 Million | ▼ -120.3% |
| 2019 | 0.14x | $11.46 Million | $81.05 Million | ▲ +175.8% |
| 2018 | -0.19x | $-19.00 Million | $101.79 Million | ▼ -161.3% |
| 2017 | -0.07x | $-22.10 Million | $309.44 Million | ▲ +33.3% |
| 2016 | -0.11x | $-32.50 Million | $303.69 Million | ▲ +10.3% |
| 2015 | -0.12x | $-29.16 Million | $244.45 Million | — |